Module Title

ICBI’s vision is to unlock the pathways to deliver diagnostic and curative treatments for patients afflicted with neuro-degenerative diseases and various cancers that currently cannot be reached by drugs blocked by the blood-brain barrier or cell membranes. Our technology simultaneously binds to multiple disease specific biomarkers to target pathological lesions in the brain to trigger a disease modifying response. Development of biologics that specifically target pathologic proteins offer clinical potential for early diagnosis, monitoring of disease progression, and increased therapeutic efficacy of drugs.